Lab
Cunningham Pathology, LLC
Cunningham Pathology, LLC was paid $5.14M by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 87801, Infectious agent detection by nucleic acid; amplified probe, multiple organisms — 22% of everything it billed.
33Billing provider infoCUNNINGHAM PATHOLOGY, LLC
BIRMINGHAM, AL 35213
BIRMINGHAM, AL 35213
33aNPI1730185455assigned 06/27/2005
33bProvider typeClinical Medical Laboratory
28Total paid$5.14M
24GClaims202,293
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Alabama
Rank by total paid#14 of 61
Median peer was paid$46K
This provider vs. median113×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,413 | $731K | |
| 2019 | 28,853 | $814K | |
| 2020 | 26,062 | $812K | |
| 2021 | 32,619 | $930K | |
| 2022 | 29,870 | $799K | |
| 2023 | 35,200 | $706K | |
| 2024incomplete | 14,276 | $352K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 22% | 28,423 | 24,214 | $1.13M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 18% | 28,475 | 24,337 | $951K |
| 88307 | 9.7% | 8,722 | 7,827 | $499K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 9.3% | 27,597 | 23,954 | $479K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 9.0% | 12,352 | 8,850 | $463K |
| 87481 | 7.0% | 10,379 | 5,633 | $359K | |
| 88304 | 3.5% | 8,938 | 7,973 | $179K | |
| 87511 | 3.4% | 11,024 | 7,850 | $177K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3.3% | 11,652 | 10,027 | $170K |
| 88342 | 1.7% | 3,756 | 3,165 | $87K | |
| 88341 | 1.6% | 1,990 | 1,643 | $83K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 6,786 | 5,785 | $80K |
19 more codes
| 88141 | 1.4% | 6,461 | $70K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 7,082 | $56K |
| 88112 | 1.1% | 2,232 | $55K | |
| 88312 | <1% | 3,242 | $51K | |
| 88302 | <1% | 3,000 | $49K | |
| 87653 | <1% | 5,488 | $48K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,363 | $40K |
| 88142 | <1% | 2,132 | $36K | |
| 87529 | <1% | 1,201 | $31K | |
| 88313 | <1% | 1,093 | $19K | |
| 88311 | <1% | 1,944 | $12K | |
| 88360 | <1% | 146 | $8K | |
| 88331 | <1% | 321 | $6K | |
| 88173 | <1% | 241 | $3K | |
| 88309 | <1% | 15 | $501.00 | |
| 87563 | <1% | 1,305 | $340.92 | |
| 85060 | <1% | 833 | $280.73 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 78 | $104.00 |
| 87081 | <1% | 22 | $96.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHALL, SHEILA (CREDENTIALING COORDINATOR)
Parent organizationCUNNINGHAM PATHOLOGY, LLC
| Provider | Location | Paid |
|---|---|---|
| Va N Motion LLC | Colonial Heights, VA | $759.49 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.